Cargando…
Engineering Concanavalin B to Release Bioactive Peptides against Metabolic Syndrome
Metabolic syndrome is a severe public health issue characterized by multiple metabolic disturbances. Current treatments prescribe a particular drug for each of them, producing multiple side effects. As a first step towards a more integral approach, we applied our recently described methodology to de...
Autores principales: | Maldonado-Torres, Diego Armando, Jara-Romero, G. Janet, Rosas-Cárdenas, Flor de Fátima, Fernández-Velasco, D. Alejandro, Luna-Suárez, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307266/ https://www.ncbi.nlm.nih.gov/pubmed/34359424 http://dx.doi.org/10.3390/foods10071554 |
Ejemplares similares
-
Bioactive peptides produced by engineered probiotics and other food-grade bacteria: A review
por: Romero-Luna, Haydee Eliza, et al.
Publicado: (2021) -
Concanavalin A as a Tool
por: Bazill, G. W.
Publicado: (1977) -
Release of endogenous pyrogen-activating factor from concanavalin A- stimulated human lymphocytes
Publicado: (1980) -
Inhibition of intercellular adhesion by concanavalin A is associated with concanavalin A-mediated redistribution of surface receptors
Publicado: (1979) -
Concanavalin A receptors, immunoglobulins, and theta antigen of the lymphocyte surface. Interactions with concanavalin A and with Cytoplasmic structures
Publicado: (1975)